Carl Zeiss Meditec and Optovue Settle Dispute
DUBLIN, Calif. & FREMONT, Calif.--(BUSINESS WIRE)--Carl Zeiss Meditec Inc. (CZMI) and Optovue Corp. announced that the parties have resolved their legal disputes pending in the Northern
Read Full Article
Related Articles
- GlucoLight Corporation Raises Second Tranche of ''c'' Round Financing also published in businesswire.com
- Assessment of macular function by microperimetry in unilateral resolved central serous chorioretinopathy also categorized in Ophthalmology
- OCTANe Foundation for Innovation Grants $20,000 Innovation Award also published in businesswire.com
- Optical coherence tomography on autologous translocation of choroid and retinal pigment epithelium in age-related macular degeneration also categorized in Ophthalmology
- Automatic retinal blood flow calculation using spectral domain optical coherence tomography also categorized in Ophthalmology
- High efficiency low coherence interferometry also mentions Optovue
- Evaluation of peripapillary detachment in pathologic myopia with en face optical coherence tomography also categorized in Ophthalmology
- Change of foveal and perifoveal thickness measured by OCT after phacoemulsification and IOL implantation also categorized in Ophthalmology
- A Comparison of Macular Structure Imaged by Optical Coherence Tomography in Preterm and Full-Term Children also categorized in Ophthalmology
- GlucoLight Corporation Raises Second Tranche of “c” Round Financing also published in businesswire.com
Login to comment.